Advertisement

ASC Coding, Billing & Collections

Advertisement

An editorial by PharmExec.com editors, says United States-based healthcare executives are not interested in expanding patient-reported outcome measures. Executives are skeptical of health economics and outcomes researchers that drug manufacturers pay to conduct studies, according to a report by Burlington,…

After Vice President Mike Pence and other Trump administration officials resurrected a version of the American Health Care Act, U.S. House conservatives objected to the measure on April 5, 2017, the New York Times reports.

Advertisement